Cargando…
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
Dysregulated long noncoding RNAs (lncRNAs) are potential markers of several tumor prognoses. This study aimed to develop a lncRNA expression signature that can predict chemotherapeutic sensitivity for patients with advanced stage and high-grade serous ovarian cancer (HGS-OvCa) treated with platinum-...
Autores principales: | Liu, Rong, Zeng, Ying, Zhou, Cheng-Fang, Wang, Ying, Li, Xi, Liu, Zhao-Qian, Chen, Xiao-Ping, Zhang, Wei, Zhou, Hong-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428368/ https://www.ncbi.nlm.nih.gov/pubmed/28154416 http://dx.doi.org/10.1038/s41598-017-00050-w |
Ejemplares similares
-
Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts
por: Merrill, Daniel, et al.
Publicado: (2016) -
Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation
por: Li, Rui, et al.
Publicado: (2020) -
Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study
por: Liu, Rong, et al.
Publicado: (2020) -
Seven Genes Based Novel Signature Predicts Clinical Outcome and Platinum Sensitivity of High Grade IIIc Serous Ovarian Carcinoma
por: Liu, Gang, et al.
Publicado: (2018) -
A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)